Several investigators reported high DSG2 expression in melanomas, human epithelial squamous cell cancer, basal cell cancer, non-small cell lung cancer, and colonic adenocarcinoma [52–55]. This evidence concerns the gene DSG2 and colon adenocarcinoma.